Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades

Purpose. To investigate a frequency of antibody response to SEREX-identified medullary breast carcinoma autoantigens ZRF1 and KRR1 in sera of breast cancer patients taking into account clinical and molecular characteristics of tumors for opening of new perspectives in creation of minimally invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyachenko, Lada, Havrysh, Kristina, Lytovchenko, Anita, Dosenko, Irina, Antoniuk, Stepan, Filonenko, Valeriy, Kiyamova, Ramziya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099469/
https://www.ncbi.nlm.nih.gov/pubmed/27847402
http://dx.doi.org/10.1155/2016/5128720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099469/
https://www.ncbi.nlm.nih.gov/pubmed/27847402
http://dx.doi.org/10.1155/2016/5128720

Ejemplares similares